Gene · 79679
Papers2,409
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 2,409
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrative proteomic characterization of adenocarcinoma of esophagogastric junction. | Nat Commun | 2023 | 36774361 | PubTator, text mining | PubMed |
| The Immune Checkpoint Landscape in Tumor Cells of Pancreatic Ductal Adenocarcinoma. | Int J Mol Sci | 2023 | 36768480 | PubTator, text mining | PubMed |
| Advances of Wnt Signalling Pathway in Colorectal Cancer. | Cells | 2023 | 36766788 | PubTator, text mining | PubMed |
| Identification and validation of a novel senescence-related biomarker for thyroid cancer to predict the prognosis and immunotherapy. | Front Immunol | 2023 | 36761753 | PubTator, text mining | PubMed |
| EZH2-regulated immune risk score prognostic model predicts outcome of clear cell renal cell carcinoma. | Transl Androl Urol | 2023 | 36760869 | PubTator, text mining | PubMed |
| A glycolysis-related gene signatures in diffuse large B-Cell lymphoma predicts prognosis and tumor immune microenvironment. | Front Cell Dev Biol | 2023 | 36755971 | PubTator, text mining | PubMed |
| Adoptive cellular immunotherapy for solid neoplasms beyond CAR-T. | Mol Cancer | 2023 | 36750830 | PubTator, text mining | PubMed |
| Regulatory cells and the effect of cancer immunotherapy. | Mol Cancer | 2023 | 36739406 | PubTator, text mining | PubMed |
| Single-cell spatial landscapes of the lung tumour immune microenvironment. | Nature | 2023 | 36725934 | PubTator, text mining | PubMed |
| Single-cell spatial landscape of immunotherapy response reveals mechanisms of CXCL13 enhanced antitumor immunity. | J Immunother Cancer | 2023 | 36725085 | PubTator, text mining | PubMed |
| Novel cuproptosis-related long non-coding RNA signature to predict prognosis in prostate carcinoma. | BMC Cancer | 2023 | 36717792 | PubTator, text mining | PubMed |
| ANXA10 is a prognostic biomarker and suppressor of hepatocellular carcinoma: a bioinformatics analysis and experimental validation. | Sci Rep | 2023 | 36709331 | PubTator, text mining | PubMed |
| High-throughput screen in vitro identifies dasatinib as a candidate for combinatorial treatment with HER2-targeting drugs in breast cancer. | PLoS One | 2023 | 36706086 | PubTator, text mining | PubMed |
| Association between HMGA1 and immunosuppression in hepatocellular carcinoma: A comprehensive bioinformatics analysis. | Medicine (Baltimore) | 2023 | 36705364 | PubTator, text mining | PubMed |
| A ferroptosis-related prognostic model with excellent clinical performance based on the exploration of the mechanism of oral squamous cell carcinoma progression. | Sci Rep | 2023 | 36702843 | PubTator, text mining | PubMed |
| An update on autoantibodies in systemic lupus erythematosus. | Curr Opin Rheumatol | 2023 | 36695053 | PubTator, text mining | PubMed |
| A Hypoxia Molecular Signature-Based Prognostic Model for Endometrial Cancer Patients. | Int J Mol Sci | 2023 | 36675190 | PubTator, text mining | PubMed |
| B7-H4 Further Stratifies Patients With Endometrial Cancer Exhibiting a Nonspecific Molecular Profile. | Arch Pathol Lab Med | 2023 | 36669510 | PubTator, text mining | PubMed |
| Hypermethylation of HIC2 is a potential prognostic biomarker and tumor suppressor of glioma based on bioinformatics analysis and experiments. | CNS Neurosci Ther | 2023 | 36650953 | PubTator, text mining | PubMed |
| Construction and verification of a novel circadian clock related long non-coding RNA model and prediction of treatment for survival prognosis in patients with hepatocellular carcinoma. | BMC Cancer | 2023 | 36647032 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/79679/papers?page=26